Streetbeat News

Equity Actions

TANH

Tantech Holdings Ltd (NASDAQ:TANH) announced a private placement to raise $2.1 million, issuing 4.2 million units at $0.50 each, including common shares and warrants, with Maxim Group LLC as the placement agent. The closing is expected on April 24, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 7:59 pm

CDTX

Cidara Therapeutics Inc (NASDAQ:CDTX) shares fell 24.4% to $0.52 after announcing a 1-for-20 reverse stock split, approved by stockholders on April 4. The reverse split is aimed at consolidating shares and will be executed proportionally among all common stockholders, with fractional shares compensated in cash. The company remains listed on the Nasdaq Capital Market.

Portfolio Pulse from Henry Khederian

April 22, 2024 | 7:52 pm

GLOB

Analysts have mixed views on Globant (NYSE:GLOB), with 12 ratings over the last three months showing a range from bullish to indifferent. The average 12-month price target is $262.42, reflecting a slight increase from the previous target. Analyst actions include adjustments to ratings and price targets, with several analysts raising their targets while others maintain or lower them. Globant's financial performance shows strong revenue growth and asset management but challenges in profitability and equity utilization. The company's market capitalization is below the industry average, indicating it is smaller compared to peers.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 7:01 pm

CDNS

Analyst ratings for Cadence Design Systems (NASDAQ:CDNS) show a mix of bullish and bearish perspectives with a recent shift towards more positive evaluations. The average 12-month price target for CDNS has increased by 7.83% to $323.75, reflecting optimism about the company's future performance. Cadence Design Systems, a leading provider of electronic design automation software, has demonstrated strong financial health with a revenue growth rate of 18.75%, a net margin of 30.31%, and an exceptional return on equity (ROE) of 9.94%. The company's market capitalization and financial metrics indicate a robust market position and efficient cost management.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 7:00 pm

CTSH

Analyst ratings for Cognizant Tech Solns (NASDAQ:CTSH) show a mix of bullish and bearish sentiments, with a recent shift towards a more positive outlook. Over the last quarter, 7 analysts provided ratings, with the latest showing 1 bullish and 6 indifferent. The average 12-month price target is $79.43, a slight decrease from the previous $80.80. Analyst actions include both upgrades and downgrades, reflecting changes in market conditions and company performance. Cognizant's financials indicate challenges in revenue growth and ROE, but strengths in net margin, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 6:01 pm

B

Barnes Gr's (NYSE:B) short interest has increased by 12.63% since the last report, with 1.04 million shares sold short, representing 3.21% of its float. It would take about 3.53 days to cover all short positions. This rise in short interest can indicate a bearish market sentiment towards Barnes Gr, although it has less short interest compared to its peer group average of 3.67%. Short interest is a critical indicator of market sentiment and can sometimes predict future stock movements.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 6:00 pm

CIFR

Cipher Mining (NASDAQ:CIFR) has received mixed reviews from 11 analysts over the past quarter, with a shift towards more bullish ratings. The average 12-month price target has been adjusted to $5.05, down 15.83% from previous estimates. The company has shown significant financial growth, with a revenue increase of 1329.67% as of December 31, 2023, and outperforms in net margin, ROE, and ROA, while maintaining a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 6:00 pm

VAXX

Vaxxinity Inc (NASDAQ:VAXX) shares plummeted nearly 50% to $0.25 after announcing plans to voluntarily delist and deregister its Class A common stock due to non-compliance with Nasdaq's minimum bid price requirement. The company aims to concentrate on R&D efforts by eliminating the distractions of stock price fluctuations. Delisting is expected around May 9, with potential over-the-counter trading thereafter.

Portfolio Pulse from Henry Khederian

April 22, 2024 | 5:59 pm

BIO

OCX

Bio-Rad Laboratories Inc has reported an 8.99% passive stake in Oncocyte Corp as of April 15, 2024, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 5:35 pm

AFRM

AXP

BAC

BX

C

COIN

FOUR

GS

MA

V

Today's whale activity in the financials sector shows significant options trading across various stocks, indicating bullish, bearish, and neutral sentiments. Notable trades include bullish calls on BAC, C, COIN, AFRM, and GS, a bearish call on BX, bearish puts on FOUR, neutral trades on MA and V, and a bullish put on AXP. These activities suggest varying investor expectations and could influence short-term stock movements.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 5:35 pm